Form 4: Molina Healthcare Director Richard Zoretic Receives Scheduled Equity Grant

Molina Healthcare, Inc. Director Richard C. Zoretic was granted 180 shares of common stock valued at $55,000 as part of his compensation for services.

Summary

• Richard C. Zoretic, a Director of Molina Healthcare, Inc. (MOH), acquired 180 shares of common stock on July 1, 2025.
• The shares were granted under the Issuer's 2025 Equity Incentive Plan in connection with his services as a Director.
• The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter.
• The grant of 180 shares was calculated based on the closing price of Molina Healthcare's common stock on July 1, 2025, which was $306.29 per share.
• Following this transaction, Richard C. Zoretic beneficially owns 7,345 shares, which are held indirectly by the Richard Charles Zoretic Revocable Living Trust.

Sentiment

Score: 6

Explanation: The document reports a routine, pre-scheduled equity grant to a director, which is a positive for aligning interests but does not indicate significant new positive or negative developments for the company's operations or financial performance.

Positives

• The grant of stock aligns the director's interests with those of shareholders, promoting long-term value creation.
• The equity award is part of a structured compensation plan, indicating a clear and predictable approach to director remuneration.

Future Outlook

The filing details a future stock grant scheduled for July 1, 2025, as part of an ongoing equity incentive plan for directors, indicating a continued compensation structure.

Management Comments

• The grant of stock was made under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.
• The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day.

Industry Context

The granting of equity awards to directors is a common practice across various industries, including healthcare, to align the interests of board members with those of shareholders and to incentivize long-term performance and retention.

Comparison to Industry Standards

• Director equity compensation, such as the grant by Molina Healthcare, is a standard practice in publicly traded companies, including peers in the managed healthcare sector like UnitedHealth Group (UNH) or Elevance Health (ELV), though specific award values vary based on company size, performance, and compensation philosophy.
• The structure of quarterly grants based on a set dollar value is a common method to smooth out compensation and reduce the impact of short-term stock price fluctuations on the number of shares granted.

Corporate Governance

Related Party Transactions

• The shares are held indirectly by the Richard Charles Zoretic Revocable Living Trust, which is a related party to the reporting person.

Stakeholder Impact

• Shareholders: The equity grant aligns the director's financial interests with long-term shareholder value creation.

Next Steps

• Continued quarterly equity grants to directors as per the 2025 Equity Incentive Plan.

Key Dates

Keywords

Molina Healthcare, MOH, Richard Zoretic, Director Compensation, Equity Incentive Plan, Stock Grant, Insider Transaction, Form 4, Healthcare Sector